IMAX (NYSE:IMAX – Free Report) had its price objective upped by Wedbush from $46.00 to $54.00 in a research note published on Friday morning, MarketBeat Ratings reports. They currently have an outperform rating on the stock.
A number of other equities analysts have also recently commented on IMAX. The Goldman Sachs Group reiterated a “neutral” rating and issued a $42.00 target price on shares of IMAX in a report on Thursday. Benchmark reiterated a “buy” rating on shares of IMAX in a report on Monday, June 22nd. Barrington Research increased their price objective on shares of IMAX from $42.00 to $46.00 and gave the stock an “outperform” rating in a research report on Friday, May 1st. B. Riley Financial raised their price objective on shares of IMAX from $48.00 to $52.00 and gave the stock a “buy” rating in a research note on Monday. Finally, Keefe, Bruyette & Woods reiterated a “market perform” rating and issued a $60.00 target price on shares of IMAX in a research note on Friday, May 22nd. Ten investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat.com, IMAX presently has an average rating of “Moderate Buy” and a consensus target price of $50.36.
View Our Latest Stock Analysis on IMAX
IMAX Stock Down 1.7%
IMAX (NYSE:IMAX – Get Free Report) last posted its earnings results on Thursday, July 23rd. The company reported $0.43 earnings per share for the quarter, topping analysts’ consensus estimates of $0.30 by $0.13. The firm had revenue of $102.84 million for the quarter, compared to the consensus estimate of $96.09 million. IMAX had a net margin of 9.84% and a return on equity of 15.65%. The business’s quarterly revenue was up 12.2% on a year-over-year basis. During the same period in the previous year, the firm posted $0.26 EPS. As a group, analysts anticipate that IMAX will post 1.3 EPS for the current year.
Insider Activity at IMAX
In other news, CEO Richard L. Gelfond sold 8,943 shares of the stock in a transaction that occurred on Monday, April 27th. The stock was sold at an average price of $37.33, for a total transaction of $333,842.19. Following the transaction, the chief executive officer owned 765,002 shares in the company, valued at $28,557,524.66. This trade represents a 1.16% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 20.55% of the stock is owned by company insiders.
Institutional Trading of IMAX
Hedge funds and other institutional investors have recently modified their holdings of the stock. CIBC Private Wealth Group LLC acquired a new stake in IMAX during the third quarter worth $27,000. Quarry LP increased its position in shares of IMAX by 166.8% during the fourth quarter. Quarry LP now owns 875 shares of the company’s stock valued at $32,000 after acquiring an additional 547 shares during the last quarter. Caitong International Asset Management Co. Ltd raised its stake in shares of IMAX by 2,310.4% in the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 1,157 shares of the company’s stock valued at $38,000 after acquiring an additional 1,109 shares during the period. Torren Management LLC purchased a new stake in shares of IMAX in the 4th quarter valued at approximately $40,000. Finally, Aster Capital Management DIFC Ltd boosted its position in shares of IMAX by 863.0% during the fourth quarter. Aster Capital Management DIFC Ltd now owns 1,666 shares of the company’s stock worth $62,000 after buying an additional 1,493 shares during the period. 93.51% of the stock is owned by institutional investors and hedge funds.
More IMAX News
Here are the key news stories impacting IMAX this week:
- Positive Sentiment: IMAX reported better-than-expected second-quarter results, with EPS and revenue both topping Wall Street estimates, while management reaffirmed full-year guidance and highlighted margin expansion and network growth. IMAX Corporation Reports Second Quarter 2026 Results
- Positive Sentiment: Strong box-office traction for The Odyssey is boosting confidence that IMAX can sustain higher ticket sales and premium-screen utilization, with reports suggesting the film could be a transformational release for the company. The Odyssey is cleaning up for IMAX. Expect the momentum to continue
- Positive Sentiment: Analysts turned more bullish after earnings, with JPMorgan, Wells Fargo, Barrington, and Wedbush all raising price targets, and Wedbush reiterating Outperform on expectations for a stronger film pipeline, market-share gains, and international expansion. IMAX price target boosted by Wedbush on growth outlook
- Positive Sentiment: Investor attention is also being reinforced by unusual call-option activity and multiple stories about sold-out IMAX 70mm showings, signaling strong near-term demand sentiment around the stock. Imax’s CEO says it’s time to hike prices as tickets to ‘The Odyssey’ resell for $1,000
- Neutral Sentiment: IMAX disclosed a new regulatory risk tied to geopolitical, trade, and other global expansion challenges, which could matter over time but does not appear to be driving near-term trading. IMAX Confronts Rising Geopolitical, Regulatory and Trade Risks Threatening Global Expansion
About IMAX
IMAX Corporation is a global leader in immersive entertainment technologies, specializing in the design, manufacture and distribution of high-resolution cameras, projectors, and proprietary software solutions that enhance both film production and theatrical exhibition. The company licenses its premium large-format system to theatre owners and filmmakers around the world, enabling audiences to experience movies with greater clarity, scale and sound fidelity. IMAX also offers turnkey theatre development services, assisting cinema operators with auditorium design, installation and custom branding to optimize the customer experience.
Founded in 1967 and headquartered in Mississauga, Ontario, IMAX has built a reputation for pioneering film-format innovations, including its patented dual 15-perforation, 70-millimeter projection system.
Recommended Stories
- Five stocks we like better than IMAX
- AMD and Cerbras Create A New Blueprint For Hardware
- Intel Earnings Reveal Whether the Chip Selloff Created a Buy
- CrowdStrike’s Cerebras Deal Puts Its AI Security Strategy to the Test
- Plugging In: How Kinder Morgan Powers Up Profits
Receive News & Ratings for IMAX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IMAX and related companies with MarketBeat.com's FREE daily email newsletter.
